US Patent 11124502 Neprilysin inhibitors
Patent 11124502 was granted and assigned to Theravance on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+84 characters)
Article
Patent abstract
In one aspect, the invention relates to compounds having the formula:
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Adam D. Hughes0
Melissa Fleury0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11124502 Neprilysin inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11124502
Date of patent
September 21, 2021
Patent application number
20200110
Date Filed
January 10, 2020
Find more entities like US Patent 11124502 Neprilysin inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
